Rapid Molecular Diagnosis of Strep A Infections Now Available in Multiple US Healthcare Settings
By LabMedica International staff writers Posted on 10 Aug 2015 |
Image: Alere i Strep A: The molecular platform that detects Group A Streptococcus (GAS) bacteria in eight minutes or less (Photo courtesy of Alere).
A molecular diagnostic platform that detects Group A Streptococcus (GAS) infections in eight minutes or less was awarded a CLIA (Clinical Laboratory Improvement Amendments) waiver by the [US] Food and Drug Administration, which paves the way for its use in a broad range of healthcare settings.
The Alere Inc. (Waltham, MA, USA) i Strep A test, which was initially approved for diagnostics use in the USA in April 2015, now joins the Alere i Influenza A & B assay as the first-ever molecular tests to receive a CLIA waiver.
Alere i Strep A detects GAS bacteria in throat swab specimens using the company's proprietary Molecular in Minutes (MIM) isothermal nucleic acid amplification technology (iNAT). Unlike polymerase chain reaction (PCR) tests, iNAT does not require lengthy and complex thermocycling or DNA purification and can therefore deliver PCR-caliber results more quickly and in a broad range of settings. Thus rapid (less than eight minutes) GAS diagnostics will be available in a broad range of healthcare settings, including physician offices, hospital emergency rooms, and retail and walk-in clinics in the USA.
“Strep A is highly transmissible, and prompt treatment is critical to reducing the spread of the infection to others. With CLIA waiver for the Alere i Strep A test, we can help link more people to early treatment by bringing rapid molecular diagnosis to even more settings where they seek health care,” said Avi Pelossof, global president of infectious disease at Alere.
Related Links:
Alere Inc.
The Alere Inc. (Waltham, MA, USA) i Strep A test, which was initially approved for diagnostics use in the USA in April 2015, now joins the Alere i Influenza A & B assay as the first-ever molecular tests to receive a CLIA waiver.
Alere i Strep A detects GAS bacteria in throat swab specimens using the company's proprietary Molecular in Minutes (MIM) isothermal nucleic acid amplification technology (iNAT). Unlike polymerase chain reaction (PCR) tests, iNAT does not require lengthy and complex thermocycling or DNA purification and can therefore deliver PCR-caliber results more quickly and in a broad range of settings. Thus rapid (less than eight minutes) GAS diagnostics will be available in a broad range of healthcare settings, including physician offices, hospital emergency rooms, and retail and walk-in clinics in the USA.
“Strep A is highly transmissible, and prompt treatment is critical to reducing the spread of the infection to others. With CLIA waiver for the Alere i Strep A test, we can help link more people to early treatment by bringing rapid molecular diagnosis to even more settings where they seek health care,” said Avi Pelossof, global president of infectious disease at Alere.
Related Links:
Alere Inc.
Latest Technology News
- New Diagnostic System Achieves PCR Testing Accuracy
- DNA Biosensor Enables Early Diagnosis of Cervical Cancer
- Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
- Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
- First of Its Kind Technology Detects Glucose in Human Saliva
- Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop
- Novel Noninvasive Test Detects Malaria Infection without Blood Sample
- Portable Optofluidic Sensing Devices Could Simultaneously Perform Variety of Medical Tests
- Point-of-Care Software Solution Helps Manage Disparate POCT Scenarios across Patient Testing Locations
- Electronic Biosensor Detects Biomarkers in Whole Blood Samples without Addition of Reagents
- Breakthrough Test Detects Biological Markers Related to Wider Variety of Cancers
- Rapid POC Sensing Kit to Determine Gut Health from Blood Serum and Stool Samples
- Device Converts Smartphone into Fluorescence Microscope for Just USD 50
- Wi-Fi Enabled Handheld Tube Reader Designed for Easy Portability